Production of hematopoietic colony-stimulating factors by human natural killer cells.
about
Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoterEffector mechanisms of rejectionCardiomyopathy associated with high-dose interleukin-2 therapy.Functional CD32 molecules on human NK cells.Regulation of human NK-cell cytokine and chemokine production by target cell recognition.The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiologyProduction of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.IgE receptor-positive non-B/non-T cells dominate the production of interleukin 4 and interleukin 6 in immunized mice.Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production.Human NK cells in health and disease: clinical, functional, phenotypic and DNA genotypic characteristics.Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cellsMolecular cloning of gp42, a cell-surface molecule that is selectively induced on rat natural killer cells by interleukin 2: glycolipid membrane anchoring and capacity for transmembrane signaling.Lymphocyte adhesion-dependent calcium signaling in human endothelial cellsIn vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytesPhysical and functional association of p56lck with Fc gamma RIIIA (CD16) in natural killer cells.Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cellsA requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.The natural killer cell: a further innate mediator of gouty inflammation?Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokinesIFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.Memory of Natural Killer Cells: A New Chance against Mycobacterium tuberculosis?Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.Role of human natural killer cells in health and disease.Immunoregulatory effects of cytokines on natural killer cells.Calcium-dependent and oncogenic IL-3 mRNA stabilization can be distinguished pharmacologically and by sequence requirements in the 3'UTR.Flow cytometric visualisation of cytokine production by CD3-CD56+ NK cells and CD3+CD56+ NK-T cells in whole blood.Arousal and inhibition of human NK cells.Production of the growth factors GM-CSF, G-CSF, and VEGF by human peripheral blood cells induced with metal complexes of human serum γ -globulin formed with copper or zinc ions.Enhanced lymphokine-activated killer cell activity by an immunomodulator, RoquinimexSignaling through CD38 induces NK cell activation.Induction of TNF-α production by metal complexes of γ-globulin fraction proteins and copper and zinc cations.Activated CD3- CD16+ natural killer cells express a subset of the lymphokine genes induced in activated alpha beta + and gamma delta + T cells.Changes in immune cell distribution and IL-10 production are regulated through endometrial IP-10 expression in the goat uterus.Monoclonal antibody gene transfer. Implications for tumor-specific cell-mediated cytotoxicity.Echinacea-Based Dietary Supplement Does Not Increase Maximal Aerobic Capacity in Endurance-Trained Men and Women.Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?Immune effects of nickel.Involvement of granulocyte colony-stimulating factor in proliferation of adult T-cell leukemia cells.
P2860
Q24311434-DF644320-0FEB-4EE3-B4F4-EFBF44E039CAQ27027082-A09902CD-1D58-4DEE-80C8-0D5B44A2ADB4Q33559591-8AE7D849-55BF-49DA-86B8-4E6636CC9EFFQ33747251-445D7E3A-ECF6-4C7D-B4CA-24AFBC9A89D4Q33747309-FA3D41E5-9CEB-4977-BFD1-4CD08CB15BB0Q33781851-682B4DA0-A7C6-4705-9331-1C58D192CD09Q34225129-C96A6F73-D12E-4A13-B031-E63C0556D0B1Q34476426-FD39957C-EDA5-4D84-B7E2-D8F3190100C0Q35557759-1169EC90-9777-4AFD-8D12-1BBF60727936Q35664711-A7D5FDA3-7575-4679-83A1-EC7A33796D50Q36010408-EBB127E2-BD7F-4806-9170-A527C7465071Q36229805-C223621C-CBE6-4B0D-BF44-8ECF6F78DFBFQ36235358-9E737AFB-7BF5-4626-862E-47212C7DCC0CQ36350708-2B6174F2-897B-40C4-9E9C-E65BE5FF3B05Q36356764-02C74688-A546-4DD2-B273-285A86209328Q36361708-B2F248E9-7048-42F3-A323-83CCB63717CFQ36365733-C54F6FD0-88AB-4B61-9D65-535E212D7663Q36401340-4C129F65-845B-42BB-911B-A0B9AB308DDFQ36403580-0BC2942C-DAE4-4898-804A-1ED2D597A2A0Q37638179-CA620C63-EF7D-4439-9EE1-D87BED6856A6Q37697703-B8C03152-09B6-4712-9770-F55C3D08BB15Q40047510-14496919-9B03-42EB-88EF-BFC77937307DQ40064112-535B935E-8922-4F39-AC63-9138CDB85A7CQ40151083-646F9AD9-39BD-4353-A93F-599CB758F1D9Q40381629-D192E27F-E3C9-4B32-9677-412A8F7F5AB2Q40681687-6125A7AD-65F5-4A20-933B-265C8F765C5CQ40851169-B03E3203-6A50-4411-8F38-20AAA0FFB438Q40902733-26288D4C-4DD9-4ED7-AC98-1A53845BFBCFQ41373731-E994A8B0-590B-4852-8A18-8FE1F08805D2Q41872476-C86E24A9-9132-4FBA-96A1-D21944FF06B8Q41889708-B795BD18-A2E4-486F-92FD-B8601A613EF4Q43562658-224A857F-F2C3-4099-BCE2-A67C6D5F7FCFQ44732419-F2B33143-4F77-4C84-9818-657453BC0AD8Q45112825-CA3602F9-0DFC-4473-8633-2AC55F9A61F8Q45236181-FCB42B43-DCE1-49DC-9895-6B11DC58B300Q46149201-E457107B-886C-4490-A0B1-ABE9229E2300Q50437841-EBC911C0-9FC2-439F-BE2B-364ABA7C01BCQ52129115-E0655BC8-C19D-486B-A454-722BBF205C0AQ52286491-A411F477-ACC7-4B22-A34E-4ADB44055136Q55240180-FBA257C5-AAEA-415B-8104-415FCDD5B4EF
P2860
Production of hematopoietic colony-stimulating factors by human natural killer cells.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Production of hematopoietic colony-stimulating factors by human natural killer cells.
@ast
Production of hematopoietic colony-stimulating factors by human natural killer cells.
@en
type
label
Production of hematopoietic colony-stimulating factors by human natural killer cells.
@ast
Production of hematopoietic colony-stimulating factors by human natural killer cells.
@en
prefLabel
Production of hematopoietic colony-stimulating factors by human natural killer cells.
@ast
Production of hematopoietic colony-stimulating factors by human natural killer cells.
@en
P2093
P2860
P356
P1476
Production of hematopoietic colony-stimulating factors by human natural killer cells.
@en
P2093
B Perussia
G Trinchieri
M C Cuturi
P2860
P304
P356
10.1084/JEM.169.2.569
P407
P577
1989-02-01T00:00:00Z